Acadia Pharmaceuticals Overview
Acadia Pharmaceuticals Target Price
Analysts' 12-month price predictions for ACAD.
Get informed when a big investor buys or sells
+ FollowShare Price
$25.49
Average Target Price
$36.33
42.5% upside
42.5% upside3 analysts in the last 4 months
High: $37 | Low: $36
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-07-07 | RBC CapitalBrian Abrahams | $36 | 41.2% upside |  |
| 2026-06-29 | Deutsche BankDavid Hoang | $37 | 45.2% upside | |
| 2026-06-29 | Canaccord GenuitySumant Kulkarni | $36 | 41.2% upside | |
| 2026-03-02 | William Blair | $29 | 13.8% upside | |
| 2026-02-23 | Wolfe ResearchRudy Li | $33 | 29.5% upside | |
| 2026-02-23 | Mizuho Securities | $35 | 37.3% upside | |
| 2026-02-03 | RBC Capital | $31 | 21.6% upside | |
| 2026-01-06 | UBSAshwani Verma | $40 | 56.9% upside | |
| 2026-01-05 | Needham | $34 | 33.4% upside | |
| 2025-12-16 | Piper Sandler | $37 | 45.2% upside | |
| 2025-12-16 | Stifel Nicolaus | $37 | 45.2% upside | |
| 2025-12-15 | H.C. Wainwright | $37 | 45.2% upside | |
| 2025-12-11 | Stifel NicolausPaul Matteis | $25 |  1.9% downside | |
| 2025-12-04 | UBSAshwani Verma | $35 | 37.3% upside | |
| 2025-12-02 | Mizuho Securities | $29 | 13.8% upside | |
| 2025-09-25 | Deutsche Bank | $29 | 13.8% upside | |
| 2025-09-09 | UBS | $39 | 53% upside | |
| 2025-08-08 | UBSAshwani Verma | $36 | 41.2% upside | |
| 2025-06-26 | OppenheimerMatthew Hershenhorn | $22 | 13.7% downside | |
| 2025-05-20 | Morgan StanleySean Laaman | $24 | 5.8% downside | |
| 2025-05-19 | H.C. WainwrightAndrew Fein | $32 | 25.5% upside | |
| 2025-05-19 | NeedhamAmi Fadia | $30 | 17.7% upside | |
| 2025-04-28 | UBS | $22 | 13.7% downside | |
| 2025-01-03 | GuggenheimYatin Suneja | $20 | 21.5% downside | |
| 2024-08-07 | Morgan StanleyJeffrey Hung | $20 | 21.5% downside | |
| 2024-06-26 | BMO CapitalKeith Tapper | $31 | 21.6% upside | |
| 2024-05-09 | H.C. WainwrightAndrew Fein | $27 | 5.9% upside | |
| 2024-05-09 | Robert W. BairdJoel Beatty | $28 | 9.8% upside | |
| 2024-05-09 | Mizuho SecuritiesUy Ear | $21 | 17.6% downside | |
| 2024-04-30 | UBSAshwani Verma | $27 | 5.9% upside | |
| 2024-03-12 | UBSAshwani Verma | $33 | 29.5% upside | |
| 2024-03-12 | OppenheimerJay Olson | $19 | 25.5% downside | |
| 2024-03-12 | NeedhamAmi Fadia | $32 | 25.5% upside | |
| 2024-03-12 | Canaccord GenuitySumant Kulkami | $33 | 29.5% upside | |
| 2024-03-12 | JMP SecuritiesJason Butler | $39 | 53% upside | |
| 2024-01-24 | NeedhamAmi Fadia | $37 | 45.2% upside | |
| 2022-11-14 | J.P. Morgan | $17 | 33.3% downside | |
| 2022-08-09 | Morgan Stanley | $18 | 29.4% downside | |
| 2022-08-09 | Mizuho Securities | $19 | 25.5% downside | |
| 2022-08-09 | Goldman Sachs | $15 | 41.2% downside | |
| 2022-08-09 | RBC Capital | $21 | 17.6% downside | |
| 2022-08-09 | H.C. Wainwright | $25 | 1.9% downside | |
| 2022-08-09 | Leerink Partners | $21 | 17.6% downside | |
| 2022-08-08 | Cowen & Co. | $21 | 17.6% downside | |
| 2022-07-15 | Morgan Stanley | $22 | 13.7% downside | |
| 2022-07-11 | Leerink Partners | $27 | 5.9% upside | |
| 2022-06-22 | Citigroup | $19 | 25.5% downside | |
| 2022-06-21 | Oppenheimer | $19 | 25.5% downside | |
| 2022-06-21 | Cantor Fitzgerald | $26 | 2% upside | |
| 2022-06-21 | RBC Capital | $26 | 2% upside | |